OBJ forecast some time ago that short term NPAT would be down with the focus on growing sales, so at least they highlighted this beforehand. Good to see AMP on board and a focus on customers in the financial sector.
Although the HY results were a little disappointing, I think the management have a good long term strategy and one to put in the bottom draw for positive future years.
- Forums
- ASX - By Stock
- Half Year Results
OBJ forecast some time ago that short term NPAT would be down...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.52 |
Change
0.200(1.15%) |
Mkt cap ! $1.408B |
Open | High | Low | Value | Volume |
$17.38 | $17.70 | $17.38 | $1.311M | 74.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124 | $17.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.66 | 737 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7125 | 2.750 |
2 | 1356 | 2.710 |
2 | 1194 | 2.600 |
1 | 2997 | 2.510 |
2 | 44658 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 3 | 1 |
2.790 | 3 | 1 |
2.800 | 5003 | 2 |
2.850 | 2206 | 1 |
2.950 | 354 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
OCL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online